1 Guidance

1 Guidance

This guidance replaces TA4 'Ischaemic heart disease coronary artery stents' (NICE technology appraisal 4).

Sections 1.2-1.4 of this guidance have been replaced by 'Coronary artery disease – drug-eluting stents' (NICE technology appraisal 152).

1.1 Stents should be used routinely where percutaneous coronary intervention (PCI) is the clinically appropriate procedure for patients with either stable or unstable angina or with acute myocardial infarction (MI).

1.2 This recommendation has been replaced by 'Coronary artery disease - drug-eluting stents' (NICE technology appraisal 152).

1.3 This recommendation has been replaced by 'Coronary artery disease - drug-eluting stents' (NICE technology appraisal 152).

1.4 This recommendation has been replaced by 'Coronary artery disease - drug-eluting stents' (NICE technology appraisal 152).

1.5 This guidance specifically relates to the present clinical indications for PCI and excludes conditions (such as many cases of stable angina) that are adequately managed with standard drug therapy.